Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Pharmacol Res. 2012 Aug 9;69(1):21–31. doi: 10.1016/j.phrs.2012.07.009

Figure 2. Key examples of microbial biotransformations: (A) digoxin, (B) sulfasalazine, and (C) levodopa (L-DOPA).

Figure 2

Structures were obtained from the ChemBioDraw Ultra database (version 12.0.3.1216). The known organism or enzyme responsible is indicated for each transformation.